• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Professional Introduction to 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine (CAS No. 1488852-88-5)

4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine, identified by its Chemical Abstracts Service (CAS) number 1488852-88-5, is a significant compound in the field of pharmaceutical chemistry. This pyrimidine derivative exhibits a unique structural framework that makes it a valuable intermediate in the synthesis of various biologically active molecules. The presence of multiple substituents, including a chloro group, an ethyl group, a fluoro group, and a methyl group, contributes to its diverse chemical reactivity and potential applications in drug development.

The compound's molecular structure is characterized by a six-membered pyrimidine ring, which is a common scaffold in many pharmaceutical agents. The electron-withdrawing nature of the chloro and fluoro substituents, combined with the electron-donating effect of the ethyl and methyl groups, creates a balance of electronic properties that facilitates various chemical transformations. This balance is particularly useful in medicinal chemistry for designing molecules with optimized pharmacokinetic profiles.

In recent years, 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine has garnered attention due to its role in the synthesis of novel therapeutic agents. One notable area of research involves its application in the development of antiviral and anticancer drugs. The pyrimidine core is a well-established motif in nucleoside analogs, which are known for their ability to interfere with viral replication or cancer cell proliferation. By modifying the substituents on the pyrimidine ring, chemists can fine-tune the biological activity of these compounds.

Recent studies have highlighted the compound's utility in generating fluorinated pyrimidines, which are increasingly recognized for their enhanced metabolic stability and improved oral bioavailability. The fluoro group, in particular, is a key pharmacophore that can significantly influence drug efficacy and pharmacokinetics. For instance, fluorine atoms can increase binding affinity to target enzymes or receptors by altering hydrophobic interactions and electronic distributions. This has led to the exploration of 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine as a precursor for designing next-generation therapeutics.

The ethyl and methyl groups in 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine also play crucial roles in modulating the compound's properties. The ethyl group can introduce steric hindrance or participate in hydrogen bonding interactions, while the methyl group can influence electronic effects and solubility. These features make the compound a versatile building block for synthesizing diverse scaffolds with tailored biological activities.

One cutting-edge application of this compound is in the field of kinase inhibitors, which are critical in targeted cancer therapy. Pyrimidine derivatives are frequently employed as inhibitors due to their ability to mimic natural substrates and compete with ATP binding. The structural features of 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine allow for modifications that enhance specificity against particular kinases involved in tumor growth or metastasis. Researchers have demonstrated that derivatives of this compound can exhibit potent inhibitory effects on kinases such as EGFR (epidermal growth factor receptor) and ALK (anaplastic lymphoma kinase).

The synthesis of 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine itself involves multi-step organic reactions that highlight modern synthetic methodologies. Advanced techniques such as cross-coupling reactions, nucleophilic substitutions, and fluorination methods are commonly employed to construct the desired structure efficiently. These synthetic strategies not only ensure high yields but also allow for scalability, making the compound accessible for large-scale pharmaceutical production.

The compound's potential extends beyond oncology; it has also been explored in developing treatments for infectious diseases. Pyrimidine-based molecules are known to disrupt essential metabolic pathways in pathogens such as bacteria and viruses. By incorporating structural elements like chloro and fluoro groups, chemists can enhance resistance to degradation by microbial enzymes. This has spurred interest in using 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine as a scaffold for novel antibiotics or antiviral agents.

Evaluation of 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine often involves rigorous computational studies to predict its behavior before experimental synthesis. Molecular modeling techniques help researchers understand how different substituents affect electronic distributions, solubility, and interactions with biological targets. These predictions guide experimental design and reduce trial-and-error approaches, accelerating the discovery process.

The safety profile of 4-Chloro-2-ethyl-5-fluoro-6-methylpyrimidine is another critical consideration during its development and application. While it is not classified as hazardous under standard conditions, proper handling procedures must be followed to ensure worker safety during synthesis and handling. Industrial applications require adherence to good manufacturing practices (GMP) to maintain consistency and purity standards required for pharmaceutical use.

In conclusion,4-Chloro-2-ethyl-5-fluoro- methylpyrimidine (CAS No. 1488852 88 - 5) represents an important intermediate in pharmaceutical chemistry with numerous applications across various therapeutic areas. Its unique structural features make it a valuable tool for developing novel drugs targeting cancers, infectious diseases, and other medical conditions. Ongoing research continues to uncover new possibilities for this versatile compound, underscoring its significance in modern medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)